The medical management of urolithiasis

British Journal of Medical and Surgical Urology

Volumn 3, Issue 3, 2010, Pages 87-95

  Sayer, John A ^a,b   Moochhala, Shabbir H ^b   Thomas, David J ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Diagnosis; Hypercalciuria; Nephrolithiasis; Renal calculi; Risk factors; Therapy; Uric acid; Urolithiasis

Indexed keywords

ALLOPURINOL; CAPTOPRIL; CITRATE POTASSIUM; PENICILLAMINE; PYRIDOXINE; THIAZIDE DIURETIC AGENT; TIOPRONIN;

CALCIUM INTAKE; CALCIUM STONE; CYSTINURIA; DIET RESTRICTION; FLUID INTAKE; HUMAN; HYPERCALCIURIA; HYPEROXALURIA; HYPERURICEMIA; HYPERURICOSURIA; IDIOPATHIC HYPERCALCIURIA; PRIORITY JOURNAL; REVIEW; SODIUM INTAKE; SODIUM RESTRICTION; STONE FORMATION; URIC ACID STONE; UROLITHIASIS;

EID: 77950519583     PISSN: 18759742     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjmsu.2010.02.004     Document Type: Review

References (50)

1. Lotan Y. Economics and cost of care of stone disease. Adv Chronic Kidney Dis 16 (2009) 5-10
2. The NHS Information Centre, Hospital Episode Statistics for England. Inpatient statistics: Total procedures and interventions. http://www.hesonline.nhs.uk.
3. Tiselius H-G, Alken P, Buck C, Gallucci M, Knoll T, Sarica K, et al. Guidelines on urolithiasis. European Association of Urology; 2009. http://www.uroweb.org/fileadmin/tx_eauguidelines/2008/Full/17%20Urolithiasis.pdf.
4. Kim Y.J., Ha Y.S., Jo S.W., Yun S.J., Chu I.S., Kim W.J., et al. Changes in urinary lithogenic features over time in patients with urolithiasis. Urology 74 (2009) 51-55
5. Daudon M., Traxer O., Conort P., Lacour B., and Jungers P. Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol 17 (2006) 2026-2033
6. Coe F.L., Keck J., and Norton E.R. The natural history of calcium urolithiasis. JAMA 238 (1977) 1519-1523
7. Williams R.E. Long-term survey of 538 patients with upper urinary tract stone. Br J Urol 35 (1963) 416-437
8. Rule A.D., Bergstralh E.J., Melton III L.J., Li X., Weaver A.L., and Lieske J.C. Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 4 (2009) 804-811
9. Spivacow F.R., Negri A.L., Del Valle E.E., Calvino I., and Zanchetta J.R. Clinical and metabolic risk factor evaluation in young adults with kidney stones. Int Urol Nephrol (2009)
10. Yagisawa T., Kobayashi C., Hayashi T., Yoshida A., and Toma H. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney. Am J Kidney Dis 37 (2001) 1140-1143
11. Sayer J.A. The genetics of nephrolithiasis. Nephron Exp Nephrol 110 (2008) e37-e43
12. Sayer J.A., Carr G., and Simmons N.L. Nephrocalcinosis: molecular insights into calcium precipitation within the kidney. Clin Sci (Lond) 106 (2004) 549-561
13. Moochhala S.H., Sayer J.A., Carr G., and Simmons N.L. Renal calcium stones: insights from the control of bone mineralization. Exp Physiol 93 (2008) 43-49
14. Sayer J.A., and Simmons N.L. Urinary stone formation: Dent's disease moves understanding forward. Exp Nephrol 10 (2002) 176-181
15. Parks J.H., Coe F.L., Evan A.P., and Worcester E.M. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism. BJU Int 103 (2009) 670-678
16. Timio F., Kerry S.M., Anson K.M., Eastwood J.B., and Cappuccio F.P. Calcium urolithiasis, blood pressure and salt intake. Blood Press 12 (2003) 122-127
17. Morris Jr. R.C., Schmidlin O., Frassetto L.A., and Sebastian A. Relationship and interaction between sodium and potassium. J Am Coll Nutr 25 (2006) 262S-270S
18. Roth D.A., and Breitenfield R.V. Vitamin C and oxalate stones. JAMA 237 (1977) 768
19. Pak C.Y., Poindexter J.R., Adams-Huet B., and Pearle M.S. Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 115 (2003) 26-32
20. Moe O.W. Kidney stones: pathophysiology and medical management. Lancet 367 (2006) 333-344
21. Pak C.Y., Sakhaee K., Peterson R.D., Poindexter J.R., and Frawley W.H. Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney Int 60 (2001) 757-761
22. Hall P.M. Nephrolithiasis: treatment, causes, and prevention. Cleve Clin J Med 76 (2009) 583-591
23. Silverberg S.J., and Bilezikian J.P. "Incipient" primary hyperparathyroidism: a "forme fruste" of an old disease. J Clin Endocrinol Metab 88 (2003) 5348-5352
24. Goldfarb D.S. Prospects for dietary therapy of recurrent nephrolithiasis. Adv Chronic Kidney Dis 16 (2009) 21-29
25. Borghi L., Meschi T., Amato F., Briganti A., Novarini A., and Giannini A. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155 (1996) 839-843
26. Taylor E.N., Stampfer M.J., and Curhan G.C. Obesity, weight gain, and the risk of kidney stones. JAMA 293 (2005) 455-462
27. Reddy S.T., Wang C.Y., Sakhaee K., Brinkley L., and Pak C.Y. Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism. Am J Kidney Dis 40 (2002) 265-274
28. Appel L.J., Moore T.J., Obarzanek E., Vollmer W.M., Svetkey L.P., Sacks F.M., et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 336 (1997) 1117-1124
29. Lieske J.C., Kumar R., and Collazo-Clavell M.L. Nephrolithiasis after bariatric surgery for obesity. Semin Nephrol 28 (2008) 163-173
30. Asplin J.R., and Coe F.L. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol 177 (2007) 565-569
31. Curhan G.C., Willett W.C., Rimm E.B., and Stampfer M.J. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 328 (1993) 833-838
32. Curhan G.C., Willett W.C., Speizer F.E., Spiegelman D., and Stampfer M.J. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 126 (1997) 497-504
33. Pearle M.S., Roehrborn C.G., and Pak C.Y. Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol 13 (1999) 679-685
34. Parks J.H., and Coe F.L. Evidence for durable kidney stone prevention over several decades. BJU Int 103 (2009) 1238-1246
35. Martins M.C., Meyers A.M., Whalley N.A., Margolius L.P., and Buys M.E. Indapamide (Natrilix): the agent of choice in the treatment of recurrent renal calculi associated with idiopathic hypercalciuria. Br J Urol 78 (1996) 176-180
36. Pak C.Y. Citrate and renal calculi: an update. Miner Electrolyte Metab 20 (1994) 371-377
37. Kang D.E., Sur R.L., Haleblian G.E., Fitzsimons N.J., Borawski K.M., and Preminger G.M. Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis. J Urol 177 (2007) 1358-1362
38. Taylor E.N., and Curhan G.C. Oxalate intake and the risk for nephrolithiasis. J Am Soc Nephrol 18 (2007) 2198-2204
39. Borghi L., Schianchi T., Meschi T., Guerra A., Allegri F., Maggiore U., et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346 (2002) 77-84
40. Ettinger B., Tang A., Citron J.T., Livermore B., and Williams T. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 315 (1986) 1386-1389
41. Goodyer P. The molecular basis of cystinuria. Nephron Exp Nephrol 98 (2004) e45-e49
42. Dello Strologo L., Pras E., Pontesilli C., Beccia E., Ricci-Barbini V., de Sanctis L., et al. Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification. J Am Soc Nephrol 13 (2002) 2547-2553
43. Cranidis A.I., Karayannis A.A., Delakas D.S., Livadas C.E., and Anezinis P.E. Cystine stones: the efficacy of percutaneous and shock wave lithotripsy. Urol Int 56 (1996) 180-183
44. Nakagawa Y., Asplin J.R., Goldfarb D.S., Parks J.H., and Coe F.L. Clinical use of cystine supersaturation measurements. J Urol 164 (2000) 1481-1485
45. Jaeger P., Portmann L., Saunders A., Rosenberg L.E., and Thier S.O. Anticystinuric effects of glutamine and of dietary sodium restriction. N Engl J Med 315 (1986) 1120-1123
46. Goldfarb D.S., Coe F.L., and Asplin J.R. Urinary cystine excretion and capacity in patients with cystinuria. Kidney Int 69 (2006) 1041-1047
47. Coe F.L., Parks J.H., and Asplin J.R. The pathogenesis and treatment of kidney stones. N Engl J Med 327 (1992) 1141-1152
48. Knoll T., Zollner A., Wendt-Nordahl G., Michel M.S., and Alken P. Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up. Pediatr Nephrol 20 (2005) 19-24
49. Perruzza I., Di Pietro V., Tavazzi B., Lazzarino G., Gamberini M., Barsotti P., et al. Is adenine phophorybosiltransferase deficiency a still underdiagnosed cause of urolithiasis and chronic renal failure? A report of two cases in a family with an uncommon novel mutation. NDT Plus 1 (2008) 292-295
50. Mac-Way F., Desmeules S., Latulippe E., de Cotret P.R., and Agharazii M. 2,8-Dihydroxyadeninuria-induced progressive renal failure. NDT Plus 1 (2008) 437-439